Overview

A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.
Phase:
Phase 3
Details
Lead Sponsor:
R-Bio